skip to main content
gastroenterology & hepatologyformula

MELD-Na

iatroX editorial team · Updated · Record checked · editorial policy

MELD-Na incorporates serum sodium into the standard MELD score to improve mortality prediction in cirrhosis. Hyponatraemia is common in advanced cirrhosis (dilutional, from portal hypertension) and is an independent predictor of waitlist mortality that standard MELD does not capture.

inputs

Values <125 set to 125, >137 set to 137 per formula
mmol/L
evidence

derivation

Developed by Biggins et al. (Gastroenterology 2006) demonstrating that adding serum sodium to MELD improved waitlist mortality prediction. Formula refined by Kim et al. (Hepatology 2008).

validation

Addition of sodium improved the c-statistic for 90-day waitlist mortality from 0.83 (MELD alone) to 0.87 (MELD-Na). Validated in UNOS registry data before adoption in 2016.

guideline endorsements

UNOS adopted MELD-Na for liver allocation in January 2016. EASL and AASLD reference MELD-Na. Eurotransplant also incorporates sodium-adjusted scores.

references
  1. Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130(6):1652-1660.PMID: 16697729
  2. Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. NEJM. 2008;359(10):1018-1026.PMID: 18768945
  3. Nagai S, Chau LC, Schilke RE, et al. Effects of allocating livers for transplantation based on Model for End-Stage Liver Disease–Sodium on waitlist outcomes. Gastroenterology. 2018;155(5):1451-1462.e3.PMID: 30036515
  4. Supporting guidance — hrsa.gov (checked 14 November 2026).link ↗